Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Meloxicam

Meloxicam

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Meloxicam:

 BioPortfolio Logo
COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact 1st October, 2004 Dailyupdates
COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact October 20 2004. At the beginning of October, 2004 Merck withdrew the blockbuster Vioxx (Rofecoxib) from the market. This move

This page has been viewed 23 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Meloxicam across BioPortfolio, or for Meloxicam Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.